Immu-G


Combined with:

Corticosteroids
Nplate

Indications and Reactions:

Role Indications Reactions
Secondary
Acute Lymphocytic Leukaemia 16.9%
Graft Versus Host Disease 11.7%
Cytomegalovirus Viraemia 10.4%
Prophylaxis Against Graft Versus Host Disease 9.1%
Mycosis Fungoides 7.8%
Prophylaxis 7.8%
Clostridial Infection 5.2%
Bone Marrow Conditioning Regimen 3.9%
Encephalitis 3.9%
Heart Block Congenital 3.9%
Drug Use For Unknown Indication 2.6%
Dyslipidaemia 2.6%
Encephalitis Cytomegalovirus 2.6%
Infection 2.6%
Pemphigoid 2.6%
Benign Prostatic Hyperplasia 1.3%
Depression 1.3%
Diabetes Mellitus 1.3%
Enterobacter Infection 1.3%
Hyperlactacidaemia 1.3%
Renal Failure 18.2%
Drug Exposure During Pregnancy 9.1%
Pericardial Effusion 9.1%
Pneumonia 9.1%
Septic Shock 9.1%
Thrombocytopenia 9.1%
Thrombocytosis 9.1%
Venous Pressure Jugular Increased 9.1%
Viral Infection 9.1%
Weight Decreased 9.1%
Concomitant
Idiopathic Thrombocytopenic Purpura 67.7%
Product Used For Unknown Indication 6.7%
Multiple Myeloma 5.2%
Drug Use For Unknown Indication 3.7%
Thrombocytopenia 2.3%
Cord Blood Transplant Therapy 1.7%
Immunosuppression 1.4%
Neoplasm Malignant 1.3%
Dermatomyositis 1.2%
Infection Prophylaxis 1.1%
Osteoporosis 1.0%
Decreased Appetite 0.9%
Deep Vein Thrombosis 0.9%
Multiple Sclerosis 0.9%
Renal Transplant 0.9%
Bone Marrow Conditioning Regimen 0.7%
Liver Transplant 0.7%
Pain 0.7%
Stem Cell Transplant 0.7%
Chronic Hepatic Failure 0.5%
Therapeutic Response Decreased 21.9%
Drug Ineffective 14.8%
Thrombocytopenia 13.0%
Death 12.8%
Platelet Count Decreased 4.1%
Weight Decreased 3.3%
Bone Marrow Reticulin Fibrosis 3.1%
Thrombocytosis 2.8%
Vomiting 2.8%
Hospitalisation 2.6%
Thrombosis 2.6%
Idiopathic Thrombocytopenic Purpura 2.3%
Myelodysplastic Syndrome 2.3%
Sepsis 2.3%
Splenectomy 1.8%
Vaginal Haemorrhage 1.8%
Interstitial Lung Disease 1.5%
Pulmonary Embolism 1.5%
Splenomegaly 1.5%
Headache 1.3%

Drug Data